Nasopharyngeal Carcinoma (NPC) Axitinib

NCT01249547 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Recurrent or Metastatic NPC

Interventions

DRUG: axitinib

Sponsor

Chinese University of Hong Kong